#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the oral cavity Haemophilia Cardiac arrest Frostbite Phaeochromocytoma B-cell lymphoma Breast cancer Dent's disease Turner's syndrome Head and neck cancer Glycogen storage disease type I Familial haemophagocytic lymphohistiocytosis Encephalitis autoimmune Astrocytoma Inflammatory myofibroblastic tumour More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis Arterial tortuosity syndrome Atypical teratoid/rhabdoid tumour of CNS – Treatment Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Familial amyotrophic lateral sclerosis Usher’s syndrome – Treatment Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Glomerulonephritis rapidly progressive – Trials in Disease Haemophilia B with anti factor IX – Treatment Leukoencephalopathy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cabotegravir Sodium Povidone Ciprofloxacin Baloxavir Marboxil Vibozilimod ANOC-001 Amniotic Membrane, Human Eo2317 Sacubitril RNMB2 Icosapent Ethyl Thiamine [18F]Fluoro-Peg-Folate Tetrahydrouridine Bt8009 Carcik-Cd19 Cells Bendamustine Hydrochloride Thiamine Nitrate Bp Remibrutinib Golexanolone More therapies…

    Learn about Your Condition

    Haemorrhage prophylaxis Thromboembolectomy Spinal osteoarthritis Eructation Porphyria non-acute Traumatic pain Embolism venous Krabbe's disease Polymyositis Essential thrombocythaemia Short-bowel syndrome Small for dates baby Oropharyngeal cancer Autoimmune hepatitis Coronary artery disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Sana Kliniken Duisburg GmbH

Sana Kliniken Duisburg GmbH

Zu Den Rehwiesen 7-9, Wanheimerort, Duisburg, 47055, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Vinblastine Sulfate
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Finland France Germany +4

  • Study on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ependymoma
    Investigated Drugs:
    • Sodium Valproate
    • Cisplatin
    • Cyclophosphamide
    Austria Belgium Czechia Denmark Finland France +7

  • Study on the Effectiveness of Atenativ for Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Childbirth

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Antithrombin III deficiency
    Investigated Drugs:
    • Antithrombin Iii Human
    • Human Plasma Derived Antithrombin
    Austria Czechia France Germany Hungary Italy +2

  • Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Temozolomide
    • Thiotepa
    • Carboplatin
    Austria Belgium Czechia Denmark Finland Germany +4

  • Study of autologous mature dendritic cell vaccine plus atezolizumab in patients with recurrent glioblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate
    • Atezolizumab
    Germany

  • Comparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Medulloblastoma
    Investigated Drugs:
    • Thiotepa
    • Carboplatin
    • Cisplatin
    Belgium Denmark France Germany The Netherlands

  • Study on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    2 1
    Austria Belgium Bulgaria Croatia Czechia France +6

  • Study on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate
    Germany

  • Study on the Effectiveness and Safety of Rosnilimab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Rosnilimab
    Austria Bulgaria Croatia France Germany Italy +4

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!